239 related articles for article (PubMed ID: 21266359)
1. MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase.
Zhang L; Sullivan PS; Goodman JC; Gunaratne PH; Marchetti D
Cancer Res; 2011 Feb; 71(3):645-54. PubMed ID: 21266359
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor-induced heparanase nucleolar localization augments DNA topoisomerase I activity in brain metastatic breast cancer.
Zhang L; Sullivan P; Suyama J; Marchetti D
Mol Cancer Res; 2010 Feb; 8(2):278-90. PubMed ID: 20164500
[TBL] [Abstract][Full Text] [Related]
3. Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer.
Zhang L; Ngo JA; Wetzel MD; Marchetti D
Neoplasia; 2015 Jan; 17(1):101-13. PubMed ID: 25622903
[TBL] [Abstract][Full Text] [Related]
4. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.
Ridgway LD; Wetzel MD; Ngo JA; Erdreich-Epstein A; Marchetti D
Mol Cancer Res; 2012 Jun; 10(6):689-702. PubMed ID: 22513363
[TBL] [Abstract][Full Text] [Related]
5. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of extracellular superoxide dismutase attenuates heparanase expression and inhibits breast carcinoma cell growth and invasion.
Teoh ML; Fitzgerald MP; Oberley LW; Domann FE
Cancer Res; 2009 Aug; 69(15):6355-63. PubMed ID: 19602586
[TBL] [Abstract][Full Text] [Related]
7. The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer.
Tang D; Zhang Q; Zhao S; Wang J; Lu K; Song Y; Zhao L; Kang X; Wang J; Xu S; Tian L
Clin Biochem; 2013 Jul; 46(10-11):926-32. PubMed ID: 23415719
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral miR30-based RNA interference against heparanase suppresses melanoma metastasis with lower liver and lung toxicity.
Liu XY; Tang QS; Chen HC; Jiang XL; Fang H
Int J Biol Sci; 2013; 9(6):564-77. PubMed ID: 23847439
[TBL] [Abstract][Full Text] [Related]
9. miRNA-558 promotes gastric cancer progression through attenuating Smad4-mediated repression of heparanase expression.
Zheng L; Jiao W; Song H; Qu H; Li D; Mei H; Chen Y; Yang F; Li H; Huang K; Tong Q
Cell Death Dis; 2016 Sep; 7(9):e2382. PubMed ID: 27685626
[TBL] [Abstract][Full Text] [Related]
10. Regulation of heparanase gene expression by estrogen in breast cancer.
Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
[TBL] [Abstract][Full Text] [Related]
11. miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase.
Qu H; Zheng L; Pu J; Mei H; Xiang X; Zhao X; Li D; Li S; Mao L; Huang K; Tong Q
Hum Mol Genet; 2015 May; 24(9):2539-51. PubMed ID: 25616966
[TBL] [Abstract][Full Text] [Related]
12. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4.
Okuda H; Xing F; Pandey PR; Sharma S; Watabe M; Pai SK; Mo YY; Iiizumi-Gairani M; Hirota S; Liu Y; Wu K; Pochampally R; Watabe K
Cancer Res; 2013 Feb; 73(4):1434-44. PubMed ID: 23384942
[TBL] [Abstract][Full Text] [Related]
13. Involvement of epidermal growth factor receptor overexpression in the promotion of breast cancer brain metastasis.
Nie F; Yang J; Wen S; An YL; Ding J; Ju SH; Zhao Z; Chen HJ; Peng XG; Wong ST; Zhao H; Teng GJ
Cancer; 2012 Nov; 118(21):5198-209. PubMed ID: 22510844
[TBL] [Abstract][Full Text] [Related]
14. Heparanase is involved in the proliferation and invasion of nasopharyngeal carcinoma cells.
Chen J; Zheng D; Shen J; Ruan J; Li A; Li W; Xie G; Luo X; Zhao P; Zheng H
Oncol Rep; 2013 May; 29(5):1888-94. PubMed ID: 23467769
[TBL] [Abstract][Full Text] [Related]
15. Heparanase promotes growth, angiogenesis and survival of primary breast tumors.
Cohen I; Pappo O; Elkin M; San T; Bar-Shavit R; Hazan R; Peretz T; Vlodavsky I; Abramovitch R
Int J Cancer; 2006 Apr; 118(7):1609-17. PubMed ID: 16217746
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of heparanase in glioblastoma multiforme.
Ueno Y; Yamamoto M; Vlodavsky I; Pecker I; Ohshima K; Fukushima T
J Neurosurg; 2005 Mar; 102(3):513-21. PubMed ID: 15796387
[TBL] [Abstract][Full Text] [Related]
17. miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α.
Xing F; Sharma S; Liu Y; Mo YY; Wu K; Zhang YY; Pochampally R; Martinez LA; Lo HW; Watabe K
Oncogene; 2015 Sep; 34(37):4890-900. PubMed ID: 25659578
[TBL] [Abstract][Full Text] [Related]
18. Heparanase is involved in proliferation and invasion of ovarian cancer cells.
Zheng H; Ruan J; Zhao P; Chen S; Pan L; Liu J
Cancer Biomark; 2015; 15(5):525-34. PubMed ID: 25586097
[TBL] [Abstract][Full Text] [Related]
19. Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases.
Zcharia E; Jia J; Zhang X; Baraz L; Lindahl U; Peretz T; Vlodavsky I; Li JP
PLoS One; 2009; 4(4):e5181. PubMed ID: 19360105
[TBL] [Abstract][Full Text] [Related]
20. Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo.
Zhang ZH; Chen Y; Zhao HJ; Xie CY; Ding J; Hou YT
Cancer Biol Ther; 2007 Apr; 6(4):587-95. PubMed ID: 17457040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]